ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,296.20
-0.32%
S&P ASX All Technology
4,030.80
-1.66%
Brent Oil
73.935
0.00%
US Dollar vs AUD
1.57356
0.00%
Bitcoin
96,341.77
0.21%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NovoCure Ltd (NVCR) Share Price

NovoCure Ltd

NovoCure Ltd (NVCR)

NASDAQ
22.09
0.44
(2.03%)
Closed 22 February 8:00AM
Delayed by 15 minutes
22.01
-0.08
(-0.36%)
After Hours: 11:04AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
22.01
Bid
22.00
Offer
22.29
Volume
1,032,875
21.38 Day's Range 22.135
11.70 52 Week Range 34.13
Market Cap
2.382B
Previous Close
21.65
Open
21.94
Last Trade
75
@
22.0072
Last Trade Time
Financial Volume
US$ 22,608,755
VWAP
21.8891
Average Volume (3m)
1,216,601
Shares Outstanding
108,201,434
Dividend Yield
-
PE Ratio
-11.54
Earnings Per Share (EPS)
-1.91
Revenue
509.34M
Net Profit
-207.04M

About NovoCure Ltd

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives it... NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.novocure.com
Headquarters
Jersey, Gbr
Founded
-
NovoCure Ltd is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NVCR. The last closing price for NovoCure was US$21.65. Over the last year, NovoCure shares have traded in a share price range of US$ 11.70 to US$ 34.13.

NovoCure currently has 108,201,434 shares in issue. The market capitalisation of NovoCure is US$2.34 billion. NovoCure has a price to earnings ratio (PE ratio) of -11.54.

Ask ADVFN Intelligence (AI)

NVCR Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
16 January 2025
NVCR (2.03%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
14 January 2025
NVCR (2.03%)

Form 8-K - Current report
Edgar (US Regulatory)
13 January 2025
NVCR (2.03%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
07 January 2025
NVCR (2.03%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.170.77838827838821.8422.9521.37567143922.01081839CS
4-4.89-18.178438661726.927.0320.71571541423.32618745CS
122.1510.825780463219.8634.1319.575121660128.14310213CS
264.4425.270347182717.5734.1314.17109933722.41978612CS
526.2639.74603174615.7534.1311.7125097819.59482603CS
156-52.945-70.635714762274.955120.0310.87110119736.50926118CS
260-70.68-76.25418060292.69232.7610.87100957565.60618811CS

NVCR - Frequently Asked Questions (FAQ)

What is the current NovoCure share price?
The current share price of NovoCure is US$ 22.01
How many NovoCure shares are in issue?
NovoCure has 108,201,434 shares in issue
What is the market cap of NovoCure?
The market capitalisation of NovoCure is USD 2.34B
What is the 1 year trading range for NovoCure share price?
NovoCure has traded in the range of US$ 11.70 to US$ 34.13 during the past year
What is the PE ratio of NovoCure?
The price to earnings ratio of NovoCure is -11.54
What is the cash to sales ratio of NovoCure?
The cash to sales ratio of NovoCure is 4.69
What is the reporting currency for NovoCure?
NovoCure reports financial results in USD
What is the latest annual turnover for NovoCure?
The latest annual turnover of NovoCure is USD 509.34M
What is the latest annual profit for NovoCure?
The latest annual profit of NovoCure is USD -207.04M
What is the registered address of NovoCure?
The registered address for NovoCure is NO 4 THE FORUM, GRENVILLE STREET, ST. HELIER, JERSEY, JE2 4UF
What is the NovoCure website address?
The website address for NovoCure is www.novocure.com
Which industry sector does NovoCure operate in?
NovoCure operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.52M
BOXLBoxlight Corporation
US$ 3.1099
(51.70%)
1.84M
GDEVGDEV Inc
US$ 20.90
(46.56%)
264.43k
IVVDInvivyd Inc
US$ 1.7501
(44.64%)
37.74M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.17M
DOYUDouYu International Holdings Ltd
US$ 7.19
(-55.31%)
1.28M
MNDRMobile health Network Solutions
US$ 0.5048
(-46.29%)
18.61M
BLUEbluebird bio Inc
US$ 4.09
(-41.90%)
5.44M
FLDFold Holdings Inc
US$ 6.95
(-37.39%)
488.54k
GCLGCL Global Holdings Ltd
US$ 3.83
(-31.48%)
635.26k
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
ADTXAditxt Inc
US$ 0.0922
(-22.39%)
278.25M
NVDANVIDIA Corporation
US$ 134.43
(-4.05%)
228.14M
HOLOMicroCloud Hologram Inc
US$ 1.565
(31.51%)
190.81M

NVCR Discussion

View Posts
jondoeuk jondoeuk 1 month ago
KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
👍️0
jondoeuk jondoeuk 1 month ago
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
👍️0
KIPK KIPK 1 month ago
dennisbabe - You are not smart enough to be impactful one way or another..
You are just one irrelevant poster.....
👍️0
KIPK KIPK 1 month ago
LOL - Garbage post....
👍️0
PonkenPlonken PonkenPlonken 1 month ago
thank you very much for sharing jondoeuk!
👍️0
jondoeuk jondoeuk 2 months ago
It is a pilot trial, but mPDAC is the largest category at diagnosis. Depending on the data (and if a pivotal trial ends up being successful), TTFs could eventually be used across all diagnosis categories.
👍️0
whosleftholdindabag whosleftholdindabag 2 months ago
Wishing a Happy New Year to everyone who is invested in $NVCR!
👍️0
KIPK KIPK 2 months ago
dennisdave, you & FeMike are made for each other. The two Irrelevant Scam Artistwannabies, begging for attention..

You are both piles of SSSSSSSSSSSSS.......HIT....
👍️0
KIPK KIPK 2 months ago
And you jondickuk, crawling around to save your clients from bad advise you capable of giving..

LOL....
👍️0
whosleftholdindabag whosleftholdindabag 2 months ago
$NVCR has reached its 52-week high! Wishing everyone a great weekend! GLTA
👍️0
PonkenPlonken PonkenPlonken 3 months ago
Thank you for sharing!
They seem to believe this makes it to market in CRC is my read.
👍️0
jondoeuk jondoeuk 3 months ago
A phase 2 trial, PANOVA-4, will test TTFields combined with a triplet regimen of gemcitabine, nab-paclitaxel and atezolizumab as a first-line treatment for metastatic pancreatic ductal adenocarcinoma. It has completed enrolment and the company said it expects to have data in 2026.

The primary endpoint is disease control rate (DCR). Secondary endpoints include, overall survival (OS), progression-free survival (PFS), 1-year OS rate, objective response rate (ORR), PFS at 6 months, duration of response, and safety.
👍️0
whosleftholdindabag whosleftholdindabag 3 months ago
$NVCR what a great way to kick off December, don't you know? Where are all the bloody naysayers today? We're raising a lot of money for charity! GLTA
👍️0
jondoeuk jondoeuk 3 months ago
Novocure plans to file for regulatory approval in the U.S., EU, Japan and other key markets; Zai Lab plans to file for regulatory approval in China https://www.businesswire.com/news/home/20241202363277/en/Zai-Lab-and-Novocure-Announce-Positive-Topline-Results-from-Phase-3-PANOVA-3-Clinical-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer
👍️ 1
tw0122 tw0122 3 months ago
Looking good $30 +
50% 
12:09 PM EST, 12/02/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)NovoCure's (NVCR) shares rose more than 41% in recent Monday trading after the company and Zai Lab (ZLAB) said that their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic adenocarcinoma achieved its primary endpoint, demonstrating a "statistically significant" improvement in median overall survival.NovoCure (NVCR) plans regulatory filings in the US, EU, Japan, and other major markets, while Zai Lab plans to file for regulatory approval in China, the companies said.
👍️0
PonkenPlonken PonkenPlonken 3 months ago
would love to see new session high
data is hot --- Can become SOC
👍️0
whosleftholdindabag whosleftholdindabag 3 months ago
$NVCR back above $20! GLTA
👍️0
Invest-in-America Invest-in-America 4 months ago
NVCR: One has to be patently BRAIN DEAD to attribute any significance whatsoever to the 1890's-like ELECTRICAL, cure-all, gadgets that this obvious SCAM company promotes!!!
👍️ 1
jondoeuk jondoeuk 4 months ago
FDA Approves Novocure’s Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer https://www.businesswire.com/news/home/20241015381082/en
👍️ 1 💥 1
whosleftholdindabag whosleftholdindabag 4 months ago
Lovely action AH $NVCR! I can't wait for the opening bell, wishing everyone a great evening! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 4 months ago
$NVCR great way to end the trading day! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 4 months ago
I own both $NVCR and $NWBO, all proceeds will go to charity. GLTA
👍️0
KIPK KIPK 4 months ago
Glad to see you are in the right stock, NWBO, now!!
👍️0
TiltMyBrain TiltMyBrain 6 months ago
Who is the bag holder now???

Going to single digits
👍️ 1
whosleftholdindabag whosleftholdindabag 7 months ago
Come fly with me, let's fly let's fly away! Ol blue eyes, what a beautiful voice! Great start $NVCR! GLTA
🚽 1
whosleftholdindabag whosleftholdindabag 7 months ago
Back above $20 $NVCR! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 9 months ago
Another week, another beautiful day for $NVCR shareholders! GLTA
🐀 1
whosleftholdindabag whosleftholdindabag 9 months ago
Another beautiful start of the week for $NVCR! GLTA
👍️0
KIPK KIPK 9 months ago
LOL - Go from over $200 to $20.
Wondering why this charity worker is NWBO hater.
Wondering why a self proclaimed good spirit tries so hard to destroy a great cancer therapy company. NWBO, hat is not NVCR??
A true charity worker expected to be compassionate, caring, and greatful of all possible potentials...

BUT not this guy??

You judge!!!

KARMA!!
👍️ 3 💯 2
whosleftholdindabag whosleftholdindabag 9 months ago
GO $NVCR GO! We're making A LOT of $$$$$ for charities don't you know? GLTA
⚠️ 1
whosleftholdindabag whosleftholdindabag 9 months ago
Beautiful day $NVCR! GLTA
👎️ 1 🤣 2
whosleftholdindabag whosleftholdindabag 9 months ago
It's been another great week for $NVCR! Have a wonderful weekend everyone! GLTA
👎️ 1 🚫 1 🤣 1
TiltMyBrain TiltMyBrain 10 months ago
Insiders to sell shares in 30 days
👍️ 2 💥 2
KIPK KIPK 10 months ago
LOL 🤣🤣🤣
👍️ 1 💯 1
dstock07734 dstock07734 10 months ago
Or you can simply wait.
👍️ 1 🤣 2
whosleftholdindabag whosleftholdindabag 10 months ago
Well that's fantastic mate! Perhaps I'll have my lawyer contact her, have a great weekend! GLTA
🤣 1 ⚠️ 1
dstock07734 dstock07734 10 months ago
By now, you should be smart enough to know that Laura Posner or Elliott Leary would be able to get IP address of each poster on NWBO board.
👍️ 3
dstock07734 dstock07734 10 months ago
libel? Which part is libel? Nemesis18's post style is very similar to yours, would you agree?
👍️ 3 🤣 2
whosleftholdindabag whosleftholdindabag 10 months ago
No, do you? GLTA
⚠️ 1
whosleftholdindabag whosleftholdindabag 10 months ago
I'd be careful you're getting a wee bit close to libel don't you know? GLTA
🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 10 months ago
Great way to end the week! Finish strong $NVCR! Have a great weekend everyone! GLTA
🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 10 months ago
You're posting on the wrong board mate, $NWBO is the one dealing with toxic financers go over there and post your rubbish! GLTA

Streeterville Capital, LLC is a Chicago-based company owned by John M. Fife, who has been described as a "toxic lender" for many years. Toxic financing is a type of financing that companies use when they are in poor condition and can't get financing in any other way. It can come in the form of convertible debt or convertible preferred stock and often gives the debtholder an unlimited number of common shares when they convert their debt or preferred shares to common stock.
👍️ 1
TiltMyBrain TiltMyBrain 10 months ago
Toxic financing for a company who’s price is down 90% in last 3 years
👍️ 2 💥 2
TiltMyBrain TiltMyBrain 10 months ago
Today is the pump. Tomorrow is the insider dump
👍️ 2 💥 2
KIPK KIPK 10 months ago
What a great day right Nemeses 18?
How is dat charity holding da bag???
👍️ 1 😂 2 🤣 1
KIPK KIPK 10 months ago
Gone with the wind on wings of fake therapy IMO
👍️ 1 💯 1
KIPK KIPK 11 months ago
20? including a PRE-CLINICAL???? lol
And all that unfocused activity signal the total desperation to keep the SP up IMO...

Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS
👍️0
axelvento axelvento 11 months ago
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/
👎️ 2 🤣 1
TiltMyBrain TiltMyBrain 11 months ago
https://x.com/peter_brit/status/1775041789889491437?s=46&t=1nHn7IXseo2gJ7ymtRCgUA

This ship is sinking fast!
👍️ 3 👏 3
TiltMyBrain TiltMyBrain 11 months ago
insider selling in 3...2...1...
👍️ 3 💯 3 😂 1 🤣 1

Your Recent History

NASDAQ
NVCR
NovoCure
BIT
I10515
IT0005616591 20250602 77
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads